MedPath

广东金城金素制药有限公司

Ownership
-
Established
2015-05-25
Employees
-
Market Cap
-
Website
http://gdjcjs.com/

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

76

NMPA:76

Drug Approvals

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20254292
Approval Date
May 27, 2025
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20254298
Approval Date
May 27, 2025
NMPA

Nimodipine Injection

Product Name
尼莫地平注射液
Approval Number
国药准字H20254284
Approval Date
May 27, 2025
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20254291
Approval Date
May 27, 2025
NMPA

Ertapenem Sodium for Injection

Product Name
注射用厄他培南钠
Approval Number
国药准字H20253836
Approval Date
Apr 8, 2025
NMPA

Oxacillin Sodium for Injection

Product Name
注射用苯唑西林钠
Approval Number
国药准字H20253834
Approval Date
Apr 8, 2025
NMPA

Oxacillin Sodium for Injection

Product Name
注射用苯唑西林钠
Approval Number
国药准字H20253753
Approval Date
Apr 1, 2025
NMPA

Oxacillin Sodium for Injection

Product Name
注射用苯唑西林钠
Approval Number
国药准字H20253752
Approval Date
Apr 1, 2025
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
注射用头孢哌酮钠舒巴坦钠
Approval Number
国药准字H20247151
Approval Date
Oct 29, 2024
NMPA

Cefoperazone Sodium for Injection

Product Name
注射用头孢哌酮钠
Approval Number
国药准字H20237087
Approval Date
Jul 23, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.